Tumor Growth Rates Derived from Data for Patients in a Clinical Trial Correlate Strongly with Patient Survival: A Novel Strategy for Evaluation of Clinical Trial Data

PURPOSE: The slow progress in developing new cancer therapies can be attributed in part to the long time spent in clinical development. To hasten development, new paradigms especially applicable to patients with metastatic disease are needed. PATIENTS AND METHODS: We present a new method to predict...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Stein, Wilfred D., Figg, William Doug, Dahut, William, Stein, Aryeh D., Hoshen, Moshe B., Price, Doug, Bates, Susan E., Fojo, Tito
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2008
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3313464/
https://ncbi.nlm.nih.gov/pubmed/18838440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2008-0075
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller